Zhejiang East Asia Pharmaceutical , Ltd. Current Assets

As of the most recent data (June 2026), 605177.SS shows a current assets of $980M. That compares with $1.5B in the prior-year period — down 33.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 605177.SS's current assets is now $980M (was $1.5B) — a 33.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zhejiang East Asia Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 605177.SS's current assets over time shows whether Zhejiang East Asia Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $980M That compares with $1.5B in the prior-year period — down 33.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Zhejiang East Asia Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $980M) with ownership activity and broader fundamentals.

Zhejiang East Asia Pharmaceutical , Ltd.'s current assets is $980M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.